Literature DB >> 24283223

The quest for an HIV-1 vaccine--moving forward.

Dan H Barouch1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24283223      PMCID: PMC4239025          DOI: 10.1056/NEJMp1312711

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

2.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

3.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

4.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

5.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors:  Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

  5 in total
  5 in total

1.  Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

Authors:  Dan H Barouch; Galit Alter; Thomas Broge; Caitlyn Linde; Margaret E Ackerman; Eric P Brown; Erica N Borducchi; Kaitlin M Smith; Joseph P Nkolola; Jinyan Liu; Jennifer Shields; Lily Parenteau; James B Whitney; Peter Abbink; David M Ng'ang'a; Michael S Seaman; Christy L Lavine; James R Perry; Wenjun Li; Arnaud D Colantonio; Mark G Lewis; Bing Chen; Holger Wenschuh; Ulf Reimer; Michael Piatak; Jeffrey D Lifson; Scott A Handley; Herbert W Virgin; Marguerite Koutsoukos; Clarisse Lorin; Gerald Voss; Mo Weijtens; Maria G Pau; Hanneke Schuitemaker
Journal:  Science       Date:  2015-07-02       Impact factor: 47.728

Review 2.  Novel vaccine vectors for HIV-1.

Authors:  Dan H Barouch; Louis J Picker
Journal:  Nat Rev Microbiol       Date:  2014-10-08       Impact factor: 60.633

3.  SIV-Specific Antibodies are Elicited by a Recombinant Fowlpox Virus Co-expressing SIV Gag and envT.

Authors:  Yilong Zhu; Shouwen Du; Yang Zhang; Jingwei Liu; Yan Guo; Cunxia Liu; Jieying Bai; Maopeng Wang; Fei Zhao; Tingting Cao; Wang Xu; Bing Bai; Kelong Zhang; Yizhen Ma; Chang Li; Ningyi Jin
Journal:  Indian J Microbiol       Date:  2018-04-27       Impact factor: 2.461

4.  Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.

Authors:  Stephanie Fischinger; Deniz Cizmeci; Davy Deng; Shannon P Grant; Nicole Frahm; Julie McElrath; Jonathan Fuchs; Pierre-Alexandre Bart; Giuseppe Pantaleo; Michael Keefer; William O Hahn; Nadine Rouphael; Gavin Churchyard; Zoe Moodie; Yeycy Donastorg; Hendrik Streeck; Galit Alter
Journal:  PLoS Pathog       Date:  2021-11-29       Impact factor: 7.464

Review 5.  Novel Concepts for HIV Vaccine Vector Design.

Authors:  Quazim A Alayo; Nicholas M Provine; Pablo Penaloza-MacMaster
Journal:  mSphere       Date:  2017-12-06       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.